Background*

Mr. Ernesto Bertarelli serves as Vice President at Emerging Biopharmaceutical Enterprises. Previously, Mr. Bertarelli served as the Chief Executive Officer of Merck Serono S. A. from January 1996 to January 9, 2007 and its Managing Director, Director, and Member of Executive Management Board until January 9, 2007. Mr. Bertarelli began his career at Merck Serono S.A. in 1985, where he has held several positions of increasing responsibility in Sales and Marketing. He served ... for five years as the Deputy Chief Executive Officer and Vice Chairman of the Board of Serono, where he was responsible for Finance and Operations. Mr. Bertarelli holds various Board mandates in professional organizations of the biotech and pharmaceutical industries. He serves as the Chairman of Bertarelli & Cie., PHRMA, Interpharma, Chserex in Switzerland, Kedge Capital Partners Ltd., Jersey, Team Alinghi SA, Ecublens in Switzerland, and Alinghi Holdings Ltd. in Jersey. Mr. Bertarelli serves as the Chairman of Executive Committee at Ares Life Sciences AG. He is the Chairman of the Board of Seromer Biotech SA. Mr. Bertarelli has been a Director of UBS AG since April 2002. He serves as a Director of the Bertarelli Foundation. Mr. Bertarelli serves as a Member of the Harvard Medical School Biological Chemistry and Molecular Pharmacology Advisory Council. He served as a Director of Biotechnology Industry Organization. He holds a Bachelor of Science from Babson College in Boston, Massachusetts and an M.B.A. from the Harvard Business School.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.